Abstract
Sentinel lymph node biopsy is the standard of care for axillary staging in clinically node-negative breast cancer. SLNB is predictive of axillary node status. Major concern is the occurrence of a false negative SLN. The objective of this study is to determine the rate of axillary recurrence in our series of patients in Indian cohort. The present study was conducted at Manipal Comprehensive Cancer Centre, Manipal Hospital, Bengaluru, a tertiary referral cancer centre in India, from Jan 2008 through December 2018. A total of 496 patients diagnosed with early breast cancer with clinically negative axilla underwent the SLNB procedure using both ICG and dual dye. Four hundred ninety-six patients with negative SLNB did not receive ALND. After a median follow-up of 48.8 months, 18 patients had distant metastases, one had axillary relapse, and 13 had an in-breast recurrence. The patients with axillary recurrence received axillary dissection and systemic adjuvant therapy. Data from this series, thus, showed that isolated axillary node recurrence after negative SLNB is rare (< 1%) and comparable with referral cancer institutions. We confirm that SLNB for the treatment of early breast cancer patients of a tertiary referral hospital is safe and reliable.
Similar content being viewed by others
References
Early stage breast cancer (1990) Consens Statement Natl Inst Health Consens Dev Conf 8(6):1–19
Harris JR, Osteen RT (1985) Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5(1):17–21. https://doi.org/10.1007/BF01807645
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553. https://doi.org/10.1056/NEJMoa012782
Giuliano AE, Haigh PI, Brennan MB et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 18(13):2553–2559. https://doi.org/10.1200/JCO.2000.18.13.2553
Schwartz GF, Veronesi U, Clough KB et al (2006) Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer 107(2):242–250. https://doi.org/10.1002/cncr.21988
Zavagno G, De Salvo GL, Scalco G et al (2008) A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247(2):207–213. https://doi.org/10.1097/SLA.0b013e31812e6a73
Habal N, Giuliano AE, Morton DL (2001) The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. Semin Oncol 28(1):41–52. https://doi.org/10.1016/S0093-7754(01)90044-2
Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer–a multicenter validation study. N Engl J Med 339(14):941–946. https://doi.org/10.1056/NEJM199810013391401
Classe JM, Curtet C, Campion L et al (2003) Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 29(5):426–433. https://doi.org/10.1016/s0748-7983(03)00052-0
Roumen RM, Kuijt GP, Liem IH, van Beek MW (2001) Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88:1639–1643
Veronesi U, Galimberti V, Zurrida S et al (2001) Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 37:454–458
Chung MA, Steinhoff MM, Cady B (2002) Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184:310–314
Reitsamer R, Peintinger F, Prokop E et al (2003) Sentinel lymph node biopsy alone without axillary lymph node dissection- follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29:221–223
Blanchard DK, Donohue JH, Reynolds C et al (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–488
Badgwell BD, Povoski SP, Abdessalam SF et al (2003) Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10:376–380
Naik AM, Fey J, Gemignani M et al (2004) The risk of relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 240:462–471
Winchester DJ, Sener SF, Brinkman EM et al (2004) Axillary recurrence following sentinel node biopsy. Ann Surg Oncol 11:S58
Janssen CMM, Smidt ML, Bruggink EDM et al (2004) Axillary recurrences after negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 11:S76
Van der Vegt B, Doting MH, Jager PL et al (2004) Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol 30:715–720
Torrenga H, Fabry H, Van der Sijp JR et al (2004) Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow up analysis. J Surg Oncol 88:4–8
Swenson KK, Mahipal A, Nissen MJ et al (2005) Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 104:1834–1839
Zavagno G, Carcoforo P, Franchini Z et al (2005) Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection. A study on 479 breast cancer patients. Eur J Surg Oncol 31:715–720
Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152–158
Kokke MC, Jannink I, Barneveld PC et al (2005) Incidence of axillary recurrence in 113 sentinel node negative breast cancer patients: a 3-year follow up study. Eur J Surg Oncol 31:221–225
Jeruss JS, Winchester DJ, Sener SF et al (2005) Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12:34–40
Palesty JA, Foster JM, Hurd TC et al (2006) Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 93:129–132
Takei H, Suemasu K, Kurosumi M et al (2007) Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast cancer 14:16–24
Heuts EM, van der Ent FW, Hulsewe KW et al (2007) Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients. Acta Chir Belg 107: 279–283
Bergkvist L, de Boniface J, Jönsson PE et al (2008) Axillary recurrence rate after negative sentinel node biopsy in breast cancer. Ann Surg 247:150–156
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241. https://doi.org/10.1056/NEJMoa022152
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
Taken.
Consent for Publication
Given.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Archa, P., Ashwin, K.R., Kumar, C.R. et al. Axillary Recurrence in Sentinel Lymph Node-Negative Breast Cancer Patients in a Tertiary Referral Cancer Centre. Indian J Surg 84 (Suppl 3), 677–681 (2022). https://doi.org/10.1007/s12262-021-03096-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-021-03096-3